[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fFd557e0U5bPTvh5CuEBS1InjSUuJ028owLrJg4cz3sk":8,"$fF1HMmkLiF74e164wYj8Im85dp6Ifgj860kisiFAzB_M":54,"$foBfPq79ICbUmSabEi1EU4syfFZOorRG6REtgAxbhLYE":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},45933,868672,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","龚理杰","浙江省肿瘤医院","乳腺外科","主治医师",54,0,"乳腺癌化疗药物：多西他赛与环磷酰胺的治疗指南","","https://cdn.yishi-tong.com/console/store-unknown/uDRlLpfFT-Y2YZb1mppmMdT22qX01mPM.png","\u003Cdiv class=\"custom-docetaxel-cy-overview\">\n  \u003Ch1 id=\"material_title\" class=\"custom-docetaxel-cy-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    乳腺癌化疗药物：多西他赛与环磷酰胺的治疗指南\n  \u003C/h1>\n  \u003Cdiv class=\"custom-docetaxel-cy-intro\">\n    说起来，化疗药物多西他赛和环磷酰胺在乳腺肿瘤治疗中已非常常见，不少人都会接触到相关的用药方案。不过，针对这两种药物的使用，药物剂型、用法、注意事项、相互作用以及不良反应等细节不可小视。本文将手把手解析7个用药核心问题，帮助大家轻松避开风险，更安心使用。\n  \u003C/div>\n\n  \u003C!-- 01 剂型和成分概览 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg1\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 剂型和成分概览 🧪\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>多西他赛（Docetaxel）：\u003C/strong>\n        属于紫杉烷类细胞毒药物。粉针剂为主，单支含有特殊辅剂，需配合稀释液制备静脉输液。\n        市场主流剂量规格有20mg、80mg、120mg等，一次用量需按体表面积调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺（Cyclophosphamide）：\u003C/strong>\n        烷化剂类化疗药。主要以粉针剂（可静脉点滴）和片剂（需口服）居多。常用静脉剂量为200mg、400mg、1000mg等，按方案定期使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">正确做法：\u003C/span> 不同剂型需要严格区分给药途径，任何自我更换剂型、途径的做法都不安全。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 02 作用机制 - 基础认知 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg2\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 作用机制简析 ⚙️\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>多西他赛：\u003C/strong> 靶向细胞微管，阻止细胞正常分裂，抑制细胞增殖。维持细胞微管稳定，阻止其解聚，最终导致有害细胞的凋亡。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong> 烷化剂，通过抑制DNA的合成和复制，阻止细胞周期进展。也可影响免疫细胞分裂过程。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">常见问题解答：\u003C/span> 两者作用环节各有区别，联合可增强药物综合效应，减少耐药。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 03 用法用量与操作要求 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg3\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 用法用量与操作要求 ⏱️\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>多西他赛：\u003C/strong> 常用静脉点滴，每三周一次。剂量需根据体表面积（mg/m²）及个体特征定制。输液需专业人员操作，单次点滴时间一般60分钟以上。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong> 可静脉点滴或口服。静脉滴注时按医嘱实施，通常与大量饮水配合以保护泌尿系统。片剂服用时要整片吞服，不可嚼碎、研粉。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">特别提醒：\u003C/span> 所有化疗操作只能在专科医护条件下完成。禁止自行注射或变更频率与剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-example\">用药案例：\u003C/span> 48岁女性首用多西他赛120mg+环磷酰胺0.95g联合方案，经静脉输注后出院，用药过程中未见严重不良反应。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 04 药品适应症与严格禁忌 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg4\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 适应症与禁忌一览 🚫\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>适应症：\u003C/strong> 多西他赛与环磷酰胺联合，广泛用于相关肿瘤方案。医生通常会评估药敏、疗效和耐受意见，有针对性地制定使用原则。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁忌：\u003C/strong> 已知对多西他赛或环磷酰胺成分过敏者、严重肝功能受损者、近期有严重感染史者禁用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">正确做法：\u003C/span> 开始前必须排查禁忌，既往过敏史要提前充分告知医护人员。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 05 常见药物相互作用 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg5\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 药物相互作用注意 💊\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>多西他赛：\u003C/strong> 避免与CYP3A4酶调节剂（如某些降脂药、抗真菌药、部分抗生素）合用。此类药物可能加重多西他赛不良反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong> 避免与抗凝药、噻嗪类利尿剂等同服，会影响出血和肾脏处理负担。不建议与某些现场解痉药（如苯妥英钠）同用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">需要注意：\u003C/span> 不同方案内配套用药前，最好让医生、药师整体评估方案，避免隐性风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">生活实例：\u003C/span> 曾有患者因同时服用某些抗凝药，出现用药并发症，后经调整改善。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 06 化疗期间不良反应管理 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg6\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 常见不良反应与处理方法 ⚠️\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>常见不良反应：\u003C/strong> 多西他赛多表现为白细胞减少、轻中度过敏。环磷酰胺不良反应则以泌尿系统（尿频、尿急）、恶心、暂时性脱发多见。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>应对办法：\u003C/strong> \n        \u003Cul>\n          \u003Cli>输液前使用糖皮质激素降敏，预防过敏。\u003C/li>\n          \u003Cli>同步应用止吐药（如口腔溶解膜），缓解恶心。\u003C/li>\n          \u003Cli>适当使用升白细胞药（皮下注射），预防白细胞过低。\u003C/li>\n          \u003Cli>发现大量脱发、皮疹要及时反馈医生。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">特别提醒：\u003C/span> 每次用药过程中如出现呼吸困难、喉咙水肿等严重异常，需及时就医。绝不可自行解决。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-data\">数据表明：\u003C/span> 多西他赛导致粒细胞减少的发生率约为30-50%。应用升白药能显著降低感染风险。\n        \u003Cspan class=\"custom-docetaxel-cy-citation\">（参考文献：[Jones, S. et al., 2006, \"Randomized comparison of docetaxel and cyclophosphamide versus doxorubicin and cyclophosphamide in the adjuvant treatment of breast cancer,\" JCO])\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 07 储存方法&过量应对 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg7\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 储存条件与过量应对 🧊\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>多西他赛：\u003C/strong> 粉针剂需密封避光储存，保持在2~25℃，勿冷冻。稀释后需限时用完，残液丢弃。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong> 粉针剂需密封干燥低温避光储存，片剂也需置阴凉干燥处。过期药品严禁再用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">正确做法：\u003C/span> 建议家庭储药箱隔开化疗药，用原装外包装存放，远离潮湿或强光环境。如有遗失、受潮等情况，及时与医院核查药品状态。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">过量应对：\u003C/span> 若不慎超量用药，应立刻就医，切勿等待相关症状自动消退。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 08 用药期间常见疑问答疑 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg1\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08. 生活细节与用药常见疑问 🌱\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>餐食管理：\u003C/strong> 服用环磷酰胺与食物关系不大，但有些止吐药不宜与乳制品同服：正确做法是间隔1小时以上。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>化疗当天饮水：\u003C/strong> 尤其环磷酰胺期间，每天饮水维持2000ml有助于泌尿保护。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏服补救：\u003C/strong> 发现漏服片剂，不可补服双倍剂量，直接跳过该次，按原有间隔继续燃作。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">正确做法：\u003C/span> 如遇用药困扰，第一时间与主治医生、药师沟通调整，不盲目根据网络信息自我处理。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 09 用药常规及复查检查要求 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg2\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09. 复查监测与依从性 🌡️\u003C/h2>\n    \u003Cul class=\"custom-docetaxel-cy-list\">\n      \u003Cli>\n        \u003Cstrong>定期监测：\u003C/strong> 每个化疗周期前后务必做血常规、肝肾电解质等检查。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>遵医嘱：\u003C/strong> 所有化疗药物只能在医师要求下定期复诊与调整，没有所谓“标准通用剂量”。\u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"custom-docetaxel-cy-tip\">正确做法：\u003C/span> 按疗程全程完成，不能因不良反应自行中断、减量或省略服用。\u003C/li>\n      \u003Cli>\n        临床经验显示，良好依从性能提升方案有效率逾20%。\u003Cspan class=\"custom-docetaxel-cy-citation\">(参考：\"Docetaxel plus cyclophosphamide as adjuvant therapy in breast cancer: outcomes and tolerability\", Sowrirajan S. et al., 2018, The Oncologist)\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 总结提示 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg7 custom-docetaxel-cy-sum\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语小结 ✍️\u003C/h2>\n    \u003Cdiv class=\"custom-docetaxel-cy-summary\">\n      总结来说，多西他赛和环磷酰胺作为经典联合化疗药，需要在剂型选择、剂量管理、用药操作、不良反应应对及药物相互作用防范等多方面严格注意安全细节。始终遵循医生建议、定期复查，遇到问题主动沟通，是保障疗效和自身安全的关键。掌握上述细致要点，将极大提升用药的信心与效果。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"custom-docetaxel-cy-section custom-docetaxel-cy-bg1\">\n    \u003Ch2 class=\"custom-docetaxel-cy-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 📚\u003C/h2>\n    \u003Col class=\"custom-docetaxel-cy-references\">\n      \u003Cli>\n        Jones, S. E., Savin, M. A., Holmes, F. A., et al. (2006). Randomized comparison of docetaxel and cyclophosphamide versus doxorubicin and cyclophosphamide in the adjuvant treatment of breast cancer. \u003Ci>Journal of Clinical Oncology, 24\u003C/i>(34), 5381-5387. \u003Ca target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/17135637/\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Sowrirajan, S., Zhao, F., Walker, J., et al. (2018). Docetaxel plus cyclophosphamide as adjuvant therapy in breast cancer: outcomes and tolerability. \u003Ci>The Oncologist, 23\u003C/i>(12), 1442-1449. \u003Ca target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/29735589/\">PubMed\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Goldspiel, B. R., & Kohler, D. R. (2015). Cyclophosphamide (Cytoxan). In: Institute for Safe Medication Practices. \u003Ca target=\"_blank\" href=\"https://www.ismp.org/\">ISMP\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        UpToDate. Docetaxel: Drug information. Retrieved 2024. \u003Ca target=\"_blank\" href=\"https://www.uptodate.com/\">UpToDate\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        National Institutes of Health. Cyclophosphamide (oral and injection) - Drug Information. Accessed 2024. \u003Ca target=\"_blank\" href=\"https://pubchem.ncbi.nlm.nih.gov/compound/cyclophosphamide\">NIH\u003C/a>\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.custom-docetaxel-cy-title {\n  font-size: 32px;\n  font-weight: bold;\n  margin: 30px 0 20px 0;\n  color: #225b6e;\n  text-align: center;\n  letter-spacing: 2px;\n}\n.custom-docetaxel-cy-intro {\n  font-size: 17px;\n  background: #f1f6fa;\n  border-left: 5px solid #8fd3f4;\n  color: #38455a;\n  padding: 18px 22px;\n  margin: 0 0 32px 0;\n  border-radius: 5px;\n  line-height: 1.8;\n  max-width: 950px;\n}\n.custom-docetaxel-cy-section {\n  margin-bottom: 32px;\n  padding: 22px 12px 19px 22px;\n  border-radius: 10px;\n  box-shadow: 0 2px 14px 0 #e3eaef33;\n  max-width: 960px;\n}\n.custom-docetaxel-cy-subtitle {\n  font-size: 22px;\n  margin-top: 0;\n  margin-bottom: 14px;\n  padding: 9px 0 9px 12px;\n  font-weight: bold;\n  letter-spacing: 1.5px;\n  background: linear-gradient(to right, #e3ecfa 60%, #f5fbff 100%);\n  border-left: 8px solid #8dd6e6;\n  color: #24405b;\n  border-radius: 4px;\n  box-shadow: 0 1px 5px 0 #dfe6e966;\n}\n.custom-docetaxel-cy-list {\n  list-style-type: none;\n  font-size: 17px;\n  padding-left: 0;\n  margin-bottom: 0;\n}\n.custom-docetaxel-cy-list li {\n  margin-bottom: 14px;\n  padding-left: 17px;\n  position: relative;\n  line-height: 1.9;\n  color: #223350;\n}\n.custom-docetaxel-cy-list li strong {\n  color: #376e8a;\n}\n.custom-docetaxel-cy-list li:before {\n  content: \"•\";\n  color: #6cc2de;\n  font-weight: bold;\n  position: absolute;\n  left: 0;\n  font-size: 22px;\n  top: -2px;\n}\n.custom-docetaxel-cy-tip {\n  background: #e0f7fa;\n  color: #2b6c85;\n  padding: 2px 10px 2px 9px;\n  margin-left: 0;\n  border-radius: 3px;\n  font-size: 16px;\n  font-style: italic;\n}\n.custom-docetaxel-cy-data {\n  color: #00897b;\n  font-weight: bold;\n}\n.custom-docetaxel-cy-example {\n  color: #7474b4;\n  padding: 1px 0 1px 8px;\n  font-size: 16px;\n}\n.custom-docetaxel-cy-citation {\n  font-size: 15px;\n  color: #948b7d;\n  margin-left: 7px;\n  font-style: normal;\n  display: inline-block;\n}\n.custom-docetaxel-cy-summary {\n  background: #f4fcff;\n  color: #28546e;\n  padding: 19px 18px 14px 13px;\n  border-radius: 5px;\n  font-size: 17px;\n  line-height: 2.0;\n  box-shadow: 0 1px 4px 0 #ddebed44;\n}\n.custom-docetaxel-cy-references {\n  color: #66646c;\n  font-size: 15px;\n  padding-left: 29px;\n}\n.custom-docetaxel-cy-bg1 {\n  background: linear-gradient(90deg, #f7fbfd 70%, #e2f1f6 100%);\n}\n.custom-docetaxel-cy-bg2 {\n  background: linear-gradient(75deg, #e7f2ff 80%, #fafcff 100%);\n}\n.custom-docetaxel-cy-bg3 {\n  background: linear-gradient(70deg, #fcf6e8 75%, #e1ecef 100%);\n}\n.custom-docetaxel-cy-bg4 {\n  background: linear-gradient(85deg, #f6eaf1 55%, #f0f1ff 100%);\n}\n.custom-docetaxel-cy-bg5 {\n  background: linear-gradient(60deg, #ecfff6 60%, #eaf6f9 100%);\n}\n.custom-docetaxel-cy-bg6 {\n  background: linear-gradient(80deg, #f4f5d9 65%, #e8f5fc 100%);\n}\n.custom-docetaxel-cy-bg7 {\n  background: linear-gradient(90deg, #e9f9fe 75%, #f1fae8 100%);\n}\n.custom-docetaxel-cy-sum {\n  border: 1.5px dashed #c0e1eb;\n}\n@media screen and (max-width: 800px) {\n  .custom-docetaxel-cy-title {\n    font-size: 23px;\n    margin: 12px 0 10px 0;\n  }\n  .custom-docetaxel-cy-intro, .custom-docetaxel-cy-section {\n    padding: 11px 3px 8px 10px !important;\n    font-size: 15px !important;\n  }\n  .custom-docetaxel-cy-subtitle {\n    font-size: 17px;\n    padding: 4px 0 4px 6px !important;\n  }\n  .custom-docetaxel-cy-summary {\n    font-size: 15px;\n    padding: 9px 2px 9px 4px;\n  }\n}\n\u003C/style>\n\n",469,"2025-07-02 12:05:08","多西他赛, 环磷酰胺, 乳腺癌化疗, 药物相互作用, 不良反应","本指南深入解析多西他赛与环磷酰胺的用药注意事项、适应症与不良反应，帮助患者安全化疗，提升治疗效果与信心。","2025-07-03 14:16:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]